🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center, randomized, double-blinded, placebo-controlled, dose-ran...
Status
Completed
Location
Praxis Research Site
Start Date
2021-10-14
Trial ID
NCT05021991
Treatments Being Tested
Main Study (CACZ885M2301): The purpose of the pivotal phase of this trial w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04-11
Trial ID
NCT01327846
Treatments Being Tested
Objective: Primary objective of the present study was to assess the relati...
Status
Completed
Location
Bio Evaluation Centre, Torrent Pharmaceuticals Ltd.,
Start Date
TBD
Trial ID
NCT01418586
Treatments Being Tested
AMB-051-07 is an open-label, adaptive, dose-ranging study with long-term ex...
Status
Completed
Location
AmMax Bio, Clinical Site
Start Date
2023-01-26
Trial ID
NCT05349643
Treatments Being Tested
The purpose of this study is to assess the feasibility and safety of inject...
Status
Terminated
Location
The University of Texas health Science Center at Houston
Start Date
2024-07-16
Trial ID
NCT06374290
Treatments Being Tested
This study will investigate the Safety and Tolerability of Repeated Subcuta...
Status
Completed
Location
ATP Clinical Research, Inc.
Start Date
2009-12
Trial ID
NCT01023685
Treatments Being Tested
The objective of this study is to evaluate long-term safety of gevokizumab ...
Status
Terminated
Location
Lions Eye Institute
Start Date
2014-08
Trial ID
NCT02375685
Treatments Being Tested
The first phase of this study will be a parallel, 12-week treatment, Phase ...
Status
Completed
Location
Investigational Site Number : 0320006
Start Date
2021-11-24
Trial ID
NCT05107115
Treatments Being Tested
This single-arm, open-label, multicenter extension study will provide conti...
Status
Completed
Location
A.Ö. LKH; Abt. für Lungenkrankheiten
Start Date
2012-07-13
Trial ID
NCT01588184
Treatments Being Tested
This was a multicenter, open-label study to evaluate the dose of Orenitram®...
Status
Completed
Location
University of California San Francisco - Fresno
Start Date
2019-01-31
Trial ID
NCT03497689
Treatments Being Tested